 |
 |
Hi Jeanette, Go to http://clinicaltrials.gov. Type "transdermal" AND "parkinson" in the SEARCH box. 1 hit.... Transdermal Application of Dopamine Agonist N-0923 in Parkinson's Disease (they are not telling us exactly what Agonist N-0923 is yet but we looked at all this stuff a coupla weeks back - look in the Archives under transdermal AND N-0923) click on DISPLAY STUDIES... Read all about it... There is a 1-800-411-1222 number. If you call, be sure to have the Study Number handy... Study ID Numbers 99-N-0104 NLM Identifier NCT00001931 Date study started May 5, 1999 There are hyperlinks to MEDLINEplus related topics: Parkinson's Disease and to More Information Detailed Web Page. Have a sunny day ................ murray On 6 Mar 00 at 9:14, Leo Fuhr wrote: > Larry, What drug are you receiving via the Transdermal Patch? Do you have > to be monitored daily, weekly or bi-weekly in Phase II trials? > > Jeanette Fuhr 49/47/44? > > ---------- > From: Flemco <[log in to unmask]> > To: [log in to unmask] > Subject: drug trial > Date: Monday, March 06, 2000 6:15 AM > > Janet, > > I found your article about drug trials rather interesting. Did I tell you > I > was participating in the Transdermal Patch Phase II trials. Unfortunately, > it is being received coolly by the PWP community as only 20 patients have > been enrolled nationally. There is a good chance it may not go forward for > lack of volunteers. > > I find the patch very agreeable after the first two weeks and the study has > made me realize how under-medicated I was. > > Larry > 53/dx50 > [log in to unmask] > http://bpl-online.com > > [log in to unmask]